Satellos Bioscience Inc. (MSCL) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.133x

Based on the latest financial reports, Satellos Bioscience Inc. (MSCL) has a cash flow conversion efficiency ratio of -0.133x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-9.43 Million ≈ $-6.82 Million USD) by net assets (CA$70.71 Million ≈ $51.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Satellos Bioscience Inc. for the company's overall valuation and market capitalisation.

Satellos Bioscience Inc. - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Satellos Bioscience Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Satellos Bioscience Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Satellos Bioscience Inc. ranked by their cash flow conversion efficiency. See Satellos Bioscience Inc. cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
SHANDONG BOAN BIOTECH.H 1 F:UJ9	N/A
KYE Systems Corp TW:2365	0.012x
DCX Systems Limited NSE:DCXINDIA	0.002x
Sinphar Pharmaceutical Co Ltd TW:1734	0.031x
Toro Ltd NASDAQ:TORO	0.013x
Newbury Street II Acquisition Corp Class A Ordinary Shares NASDAQ:NTWO	-0.002x
Hua Na Hydropower JSC VN:HNA	0.038x
Centaurus Metals Ltd AU:CTM	-0.097x

Annual Cash Flow Conversion Efficiency for Satellos Bioscience Inc. (2007–2025)

The table below shows the annual cash flow conversion efficiency of Satellos Bioscience Inc. from 2007 to 2025. View Satellos Bioscience Inc. (MSCL) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$27.73 Million ≈ $20.06 Million	CA$-24.01 Million ≈ $-17.37 Million	-0.866x	-135.23%
2024-12-31	CA$67.86 Million ≈ $49.09 Million	CA$-24.98 Million ≈ $-18.07 Million	-0.368x	-3.83%
2023-12-31	CA$40.67 Million ≈ $29.42 Million	CA$-14.42 Million ≈ $-10.43 Million	-0.354x	+78.84%
2022-12-31	CA$3.37 Million ≈ $2.44 Million	CA$-5.64 Million ≈ $-4.08 Million	-1.675x	-248.79%
2021-12-31	CA$10.48 Million ≈ $7.58 Million	CA$-5.03 Million ≈ $-3.64 Million	-0.480x	-105.32%
2020-12-31	CA$-183.84K ≈ $-132.98K	CA$-1.66 Million ≈ $-1.20 Million	9.030x	+291.71%
2019-12-31	CA$408.57K ≈ $295.56K	CA$-1.92 Million ≈ $-1.39 Million	-4.710x	-366.32%
2018-12-31	CA$-624.38K ≈ $-451.67K	CA$-1.10 Million ≈ $-798.83K	1.769x	+407.07%
2016-12-31	CA$2.31 Million ≈ $1.67 Million	CA$-1.33 Million ≈ $-963.36K	-0.576x	+29.65%
2015-12-31	CA$3.78 Million ≈ $2.74 Million	CA$-3.10 Million ≈ $-2.24 Million	-0.819x	-59.16%
2014-12-31	CA$5.51 Million ≈ $3.99 Million	CA$-2.84 Million ≈ $-2.05 Million	-0.514x	+82.25%
2013-12-31	CA$1.30 Million ≈ $940.12K	CA$-3.77 Million ≈ $-2.72 Million	-2.898x	-115.11%
2012-12-31	CA$2.05 Million ≈ $1.48 Million	CA$-2.76 Million ≈ $-2.00 Million	-1.347x	-87.28%
2011-12-31	CA$2.69 Million ≈ $1.95 Million	CA$-1.93 Million ≈ $-1.40 Million	-0.719x	+35.67%
2010-12-31	CA$2.38 Million ≈ $1.73 Million	CA$-2.67 Million ≈ $-1.93 Million	-1.118x	-126.79%
2009-12-31	CA$4.29 Million ≈ $3.11 Million	CA$-2.12 Million ≈ $-1.53 Million	-0.493x	+78.84%
2008-12-31	CA$1.03 Million ≈ $745.64K	CA$-2.40 Million ≈ $-1.74 Million	-2.330x	-48.35%
2007-12-31	CA$2.49 Million ≈ $1.80 Million	CA$-3.91 Million ≈ $-2.83 Million	-1.570x	--

About Satellos Bioscience Inc.

TO:MSCL Canada Biotechnology

Market Cap

$196.35 Million

CA$271.43 Million CAD

Market Cap Rank

#16718 Global

#518 in Canada

Share Price

CA$13.03

Change (1 day)

-1.81%

52-Week Range

CA$0.65 - CA$17.85

All Time High

CA$17.85